Inflammatory mediator in ocular tissue

"Inflammatory mediators in ocular tissue" is not a single molecular entity or canonical therapeutic target. Instead, it refers collectively to various biologically active molecules—including cytokines (such as interleukin 1 [IL‑1], tumor necrosis factor alpha [TNF‑α], interferon gamma [IFN‑γ]), chemokines, growth factors, neuropeptides (like substance P), and lipid-derived compounds—that orchestrate immune responses and drive inflammation within the eye[4][10]. These mediators are released by resident cells such as mast cells and infiltrating leukocytes during conditions like dry eye disease, uveitis, glaucoma-associated neuroinflammation, allergic conjunctivitis and other ocular surface inflammatory disorders[1][3][4][5]. Their actions include recruiting immune cells to sites of injury or infection; increasing vascular permeability; promoting tissue swelling; stimulating further release of pro-inflammatory signals; and contributing to both acute symptoms and chronic damage if dysregulated. Because "inflammatory mediators" encompasses many different molecules with diverse roles—and because therapies typically target specific members of these groups rather than the entire class—the term itself does not represent a precise druggable target but rather an important pathophysiological concept guiding research into more focused interventions[3][6]. **Note:** This entry is considered incorrect for use as a canonical drug discovery target because it describes a heterogeneous group rather than an individual protein/receptor/enzyme suitable for direct pharmacological intervention. For structured data purposes or database curation efforts seeking actionable targets for drug development or biomarker identification in ophthalmology/ocular immunology contexts, it is necessary to specify particular molecules—such as "Interleukin 1 beta," "Tumor necrosis factor alpha," "Interferon gamma," etc.—rather than using this umbrella term.

Other names

Ocular inflammatory mediatorInflammatory factor in ocular tissuePro-inflammatory molecule in the eyeOcular surface inflammatory mediator